ncontrol trial of rituximab treatment on steroid dependent and frequently relapsing minimal cahnge nephrotic syndrome(MCNS)
Phase 3
- Conditions
- steroid dependent and frequently relapsing minimal change nephrotic syndrome
- Registration Number
- JPRN-UMIN000005231
- Lead Sponsor
- Department of Medicine, Kidney Center, Tokyo Women's Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
positive serology for hepatitis B and C, HIV and antinuclear antibodies, sereve renal dysfunction and liver dysfunction, pregnant woman
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method relapse the cumlative dose of prednisolone the cumulative dose of cyclosporin
- Secondary Outcome Measures
Name Time Method the adverse effect of prednisolone the adverse effect of cyclosporin the adverse effect of rituximab